Peter Thompson

Peter Thompson

Vermogen: 2 M $ op 30-09-2026

67 jaar
Health Technology
Consumer Services
Finance

Profiel

Dr. Peter A. Thompson, MD, is an Independent Non-Executive Director at Sionna Therapeutics, Inc., an Independent Director at Aspen Neuroscience, Inc., a Chairman at Edgewise Therapeutics, Inc., an Independent Director at ARS Pharmaceuticals, Inc., an Independent Director at Corvus Pharmaceuticals, Inc., a General Partner at OrbiMed Advisors Private Equity and a Professor at University of Washington.
He is on the Board of Directors at Gennao Bio, Inc., Sionna Therapeutics, Inc., Aspen Neuroscience, Inc., ARS Pharmaceuticals, Inc., Corvus Pharmaceuticals, Inc., Angel Pharmaceuticals Co., Ltd., Cardioxyl Pharmaceuticals LLC, OxOnc Development LP, ReCode Therapeutics, Inc. and Terremoto Biosciences, Inc. Dr. Thompson was previously employed as an Independent Director by Janux Therapeutics, Inc., an Independent Director by Decibel Therapeutics, Inc., an Independent Director by Synthorx, Inc., an Independent Director by Prevail Therapeutics, Inc., an Independent Director by Alpine Immune Sciences, Inc., a Chairman by Silverback Therapeutics, Inc., an Independent Director by PMV Pharmaceuticals, Inc., a Non-Executive Director by Adaptimmune Ltd., an Independent Non-Executive Director by Adaptimmune Therapeutics Plc, an Independent Director by Sierra Oncology, Inc., an Independent Director by Anthera Pharmaceuticals, Inc., a Venture Partner by ATP Capital LP, a Managing Director by Strategicon Partners, a Chairman, President & Chief Executive Officer by Trubion Pharmaceuticals, Inc., a Vice President-Research & Technology by BD Biosciences, Systems & Reagents, Inc., a Vice President-Research & Technology Development by Becton Dickinson Immunocytometry Systems, a Vice President & General Manager-Informatics by Chiron Corp., and a Chairman & Chief Executive Officer by Newyu, Inc.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
11-06-2026 210.000 ( 0,25% ) 2 M $ 30-09-2026
24-06-2026 0 ( -.--% ) - $ 30-09-2026
05-06-2026 0 ( -.--% ) - $ 30-09-2026
17-06-2026 0 ( -.--% ) - $ 30-09-2026

Actieve functies van Peter Thompson

BedrijvenFunctieBegin
EDGEWISE THERAPEUTICS, INC. Oprichter 01-01-2017
CORVUS PHARMACEUTICALS, INC. Oprichter 27-01-2014
ARS PHARMACEUTICALS, INC. Directeur/Bestuurslid 08-11-2022
SIONNA THERAPEUTICS, INC. Directeur/Bestuurslid 01-02-2022
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid 16-03-2022
Oprichter -
Directeur/Bestuurslid -
░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░

Eerdere bekende functies van Peter Thompson

BedrijvenFunctieEinde
░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Peter Thompson in detail bekijken

Opleiding van Peter Thompson

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

63

Eerstegraads connecties

41

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit41

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Technology Services

Health Technology

Health Technology

Health Technology

Finance

Finance

Health Technology

Health Services

Strategicon Partners

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Peter Thompson